Defining the genomic signature of the parous breast

BMC Medical Genomics

Volumn 5, Issue , 2012, Pages

  Peri, Suraj ^a   De Cicco, Ricardo Lápez ^b   Santucci Pereira, Julia ^b   Slifker, Michael ^a   Ross, Eric A ^a   Russo, Irma H ^b   Russo, Patricia A ^b   Arslan, Alan A ^c   Belitskaya Lévy, Ilana ^c   Zeleniuch Jacquotte, Anne ^c   Bordas, Pal ^d,e   Lenner, Per ^e   Hman, Janet ^d   Afanasyeva, Yelena ^c   Johansson, Robert ^e   Sheriff, Fathima ^b   Hallmans, Göran ^e   Toniolo, Paolo ^c,f   Russo, Jose ^b  

^a Department of Biostatistics and Bioinformatics ^*  (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SUNDERBY HOSPITAL   (Sweden)

^e UMEÅ UNIVERSITY   (Sweden)

^f UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Bioinformatics.; Breast cancer risk; Breast differentiation; Breast morphology; Gene expression profiling; Normal breast transcriptome; Parous and nulliparous breast transcriptome; Pregnancy

Indexed keywords

MESSENGER RNA; SOMATOMEDIN RECEPTOR; TRANSCRIPTOME;

ADULT; AGED; APOPTOSIS; ARTICLE; BASEMENT MEMBRANE; BIOINFORMATICS; BREAST BIOPSY; BREAST CANCER; CANCER RISK; CELL DIFFERENTIATION; CELL JUNCTION; CELL PROLIFERATION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC REGULATION; GENOMICS; HEMIDESMOSOME; HUMAN; HUMAN EXPERIMENT; HUMAN GENETICS; HUMAN GENOME; HUMAN TISSUE; MOLECULAR DYNAMICS; MUSCLE CELL; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; NULLIPARA; POSTMENOPAUSE; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; RNA METABOLISM; RNA PROCESSING; RNA SPLICING; SIGNAL TRANSDUCTION;

AGED; BREAST; CLUSTER ANALYSIS; CYCLINS; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARAFFIN EMBEDDING; PARITY; PREGNANCY; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSCRIPTOME; UP-REGULATION;

EID: 84867237055     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-5-46     Document Type: Article

References (51)

1. Population attributable risk of breast cancer in white women associated with immediately modifiable risk factors. Clarke CA, Purdie DM, Glaser SL, BMC Cancer 2006 6 170 10.1186/1471-2407-6-170 16803628 (Pubitemid 44389995)
2. Cancer statistics, 2007. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ, CA Cancer J Clin 2007 57 43 66 10.3322/canjclin.57.1.43 17237035 (Pubitemid 46148091)
3. Full-term pregnancy induces a specific genomic signature in the human breast. Russo J, Balogh GA, Russo IH, Cancer Epidemiol Biomarkers Prev 2008 17 51 66 10.1158/1055-9965.EPI-07-0678 18199711 (Pubitemid 351196273)
4. Age at first birth and breast cancer risk. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S, Bull World Health Organ 1970 43 209 221 5312521
5. Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia? Thordarson G, Jin E, Guzman RC, Swanson SM, Nandi S, Talamantes F, Carcinogenesis 1995 16 2847 2853 10.1093/carcin/16. 11.2847 7586208
6. Prevention of mammary carcinogenesis in rats by pregnancy: effect of full-term and interrupted pregnancy. Sinha DK, Pazik JE, Dao TL, Br J Cancer 1988 57 390 394 10.1038/bjc.1988.88 3134040
7. Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Russo J, Russo IH, Cancer Res 1980 40 2677 2687 7388818
8. Formation and removal of 7,12-dimethylbenz[a]anthracene-nucleic acid adducts in rat mammary epithelial cells with different susceptibility to carcinogenesis. Tay LK, Russo J, Carcinogenesis 1981 2 1327 1333 10.1093/carcin/2.12.1327 6799218 (Pubitemid 12131939)
9. Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Russo IH, Koszalka M, Russo J, Br J Cancer 1991 64 481 484 10.1038/bjc.1991.335 1911188
10. Fetal and neonatal endocrinology. Fisher DA, Endocrinology Elsevier Saunders, Philadelphia, PA, DeGroot LJ, Jameson JL, 5 2006 3369 3386
11. The protective role of pregnancy in breast cancer. Russo J, Moral R, Balogh GA, Mailo D, Russo IH, Breast Cancer Res 2005 7 131 142 10.1186/bcr1029 15987443 (Pubitemid 40704134)
12. Role of differentiation in the pathogenesis and prevention of breast cancer. Russo J, Russo IH, Endocr Relat Cancer 1997 4 7 21 10.1677/erc.0.0040007 (Pubitemid 27223578)
13. Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice. Henry MD, Triplett AA, Oh KB, Smith GH, Wagner KU, Oncogene 2004 23 6980 6985 10.1038/sj.onc.1207827 15286714 (Pubitemid 39279998)
14. Chorionic gonadotropin inhibits rat mammary carcinogenesis through activation of programmed cell death. Srivastava P, Russo J, Russo IH, Carcinogenesis 1997 18 1799 1808 10.1093/carcin/18.9.1799 9328178 (Pubitemid 28134688)
15. Breast cancer: the protective effect of pregnancy. Medina D, Clin Cancer Res 2004 10 380S 384S 10.1158/1078-0432.CCR-031211 14734495 (Pubitemid 38116646)
16. Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. Ginger MR, Gonzalez-Rimbau MF, Gay JP, Rosen JM, Mol Endocrinol 2001 15 1993 2009 10.1210/me.15.11.1993 11682629 (Pubitemid 33022536)
17. Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. D'Cruz CM, Moody SE, Master SR, Hartman JL, Keiper EA, Imielinski MB, Cox JD, Wang JY, Ha SI, Keister BA, Chodosh LA, Mol Endocrinol 2002 16 2034 2051 10.1210/me.2002-0073 12198241 (Pubitemid 35013453)
18. Endocrine control of breast development. Russo J, Russo IH, Molecular basis of breast cancer: prevention and treatment Springer, Berlin, Russo J, Russo IH, 2004 64 67
19. Characterization of a genomic signature of pregnancy identified in the breast. Belitskaya-Levy I, Zeleniuch-Jacquotte A, Russo J, Russo IH, Bordas P, Ahman J, Afanasyeva Y, Johansson R, Lenner P, Li X, de Cicco RL, Peri S, Ross E, Russo PA, Santucci-Pereira J, Sheriff FS, Slifker M, Hallmans G, Toniolo P, Arslan AA, Cancer Prev Res 2011 4 1457 1464 10.1158/1940-6207.CAPR-11-0021
20. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bolstad BM, Irizarry RA, Astrand M, Speed TP, Bioinformatics 2003 19 185 193 10.1093/bioinformatics/19.2.185 12538238 (Pubitemid 36181903)
21. Adjusting batch effects in microarray expression data using empirical Bayes methods. Johnson WE, Li C, Rabinovic A, Biostatistics 2007 8 118 127 10.1093/biostatistics/kxj037 16632515 (Pubitemid 44906106)
22. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Smyth GK, Stat Appl Genet Mol Biol 2004 3 rticle3 16646809
23. Limma: linear models for microarray data. Smyth GK, Bioinformatics and Computational Biology Solutions using R and Bioconductor Springer, New York, Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, 2005 397 420
24. Bioconductor: open software development for computational biology and bioinformatics. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J, Genome Biol 2004 5 80 10.1186/gb-2004-5-10-r80 15461798
25. Controlling the false discovery rate in behavior genetics research. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I, Behav Brain Res 2001 125 279 284 10.1016/S0166-4328(01)00297-2 11682119 (Pubitemid 33000466)
26. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP, Proc Natl Acad Sci USA 2005 102 15545 15550 10.1073/pnas.0506580102 16199517 (Pubitemid 41528093)
27. Characterization of cyclin L2, a novel cyclin with an arginine/serine-rich domain: phosphorylation by DYRK1A and colocalization with splicing factors. de Graaf K, Hekerman P, Spelten O, Herrmann A, Packman LC, Bussow K, Muller-Newen G, Becker W, J Biol Chem 2004 279 4612 4624 14623875 (Pubitemid 38199053)
28. The spliceosome: design principles of a dynamic RNP machine. Wahl MC, Will CL, Luhrmann R, Cell 2009 136 701 718 10.1016/j.cell.2009.02.009 19239890
29. Identification of heterogeneous nuclear ribonucleoprotein A/B as a cytoplasmic mRNA-binding protein in early involution of the mouse mammary gland. Taga Y, Miyoshi M, Okajima T, Matsuda T, Nadano D, Cell Biochem Funct 2010 28 321 328 10.1002/cbf.1662 20517897
30. Telomeric DNA-binding activities of heterogeneous nuclear ribonucleoprotein A3 in vitro and in vivo. Huang PR, Hung SC, Wang TC, Biochim Biophys Acta 2010 1803 1164 1174 10.1016/j.bbamcr.2010.06.003 20600361
31. Differential subcellular distributions and trafficking functions of hnRNP A2/B1 spliceoforms. Han SP, Friend LR, Carson JH, Korza G, Barbarese E, Maggipinto M, Hatfield JT, Rothnagel JA, Smith R, Traffic 2010 11 886 898 10.1111/j.1600-0854.2010.01072.x 20406423
32. Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: influence of cyclin L isoforms on splice site selection. Loyer P, Trembley JH, Grenet JA, Busson A, Corlu A, Zhao W, Kocak M, Kidd VJ, Lahti JM, J Biol Chem 2008 283 7721 7732 10.1074/jbc.M708188200 18216018
33. Overexpression of cyclin L2 induces apoptosis and cell-cycle arrest in human lung cancer cells. Li HL, Wang TS, Li XY, Li N, Huang DZ, Chen Q, Ba Y, Chin Med J (Engl) 2007 120 905 909 (Pubitemid 46845932)
34. Inhibition of proliferation and differentiation and promotion of apoptosis by cyclin L2 in mouse embryonic carcinoma P19 cells. Zhuo L, Gong J, Yang R, Sheng Y, Zhou L, Kong X, Cao K, Biochem Biophys Res Commun 2009 390 451 457 10.1016/j.bbrc.2009.09.089 19785986
35. Characterization of X-chromosome inactivation status in human pluripotent stem cells. Erwin JA, Lee JT, Curr Protoc Stem Cell Biol 2010 Chapter 1 nit 1B 6 20127856
36. Reprogramming of Xist against the pluripotent state in fusion hybrids. Do JT, Han DW, Gentile L, Sobek-Klocke I, Wutz A, Scholer HR, J Cell Sci 2009 122 4122 4129 10.1242/jcs.056119 19843582
37. X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors. Vincent-Salomon A, Ganem-Elbaz C, Manie E, Raynal V, Sastre-Garau X, Stoppa-Lyonnet D, Stern MH, Heard E, Cancer Res 2007 67 5134 5140 10.1158/0008-5472.CAN-07-0465 17545591 (Pubitemid 46997249)
38. The XIST noncoding RNA functions independently of BRCA1 in X inactivation. Xiao C, Sharp JA, Kawahara M, Davalos AR, Difilippantonio MJ, Hu Y, Li W, Cao L, Buetow K, Ried T, Chadwick BP, Deng CX, Panning B, Cell 2007 128 977 989 10.1016/j.cell.2007.01.034 17350580 (Pubitemid 46350785)
39. Further evidence for BRCA1 communication with the inactive X chromosome. Silver DP, Dimitrov SD, Feunteun J, Gelman R, Drapkin R, Lu SD, Shestakova E, Velmurugan S, Denunzio N, Dragomir S, Mar J, Liu X, Rottenberg S, Jonkers J, Ganesan S, Livingston DM, Cell 2007 128 991 1002 10.1016/j.cell.2007.02.025 17350581 (Pubitemid 46341424)
40. Oxytocin receptor gene expression in rat mammary gland: structural characterization and regulation. Breton C, Di Scala-Guenot D, Zingg HH, J Mol Endocrinol 2001 27 175 189 10.1677/jme.0.0270175 11564602 (Pubitemid 32970686)
41. Oxytocin stimulates expression of a noncoding RNA tumor marker in a human neuroblastoma cell line. Koshimizu TA, Fujiwara Y, Sakai N, Shibata K, Tsuchiya H, Life Sci 2010 86 455 460 10.1016/j.lfs.2010.02.001 20149803
42. Influence of age and parity on the development of the human breast. Russo J, Rivera R, Russo IH, Breast Cancer Res Treat 1992 23 211 218 10.1007/BF01833517 1463860
43. Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway. Wilson BJ, Giguere V, Mol Cancer 2008 7 49 10.1186/1476-4598-7-49 18533032 (Pubitemid 351891429)
44. GATA3 in development and cancer differentiation: cells GATA have it! Chou J, Provot S, Werb Z, J Cell Physiol 2010 222 42 49 10.1002/jcp.21943 19798694
45. CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis. Pei XH, Bai F, Smith MD, Usary J, Fan C, Pai SY, Ho IC, Perou CM, Xiong Y, Cancer Cell 2009 15 389 401 10.1016/j.ccr.2009.03.004 19411068
46. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, Pai SY, Ho IC, Werb Z, Cancer Cell 2008 13 141 152 10.1016/j.ccr.2008.01.011 18242514 (Pubitemid 351163164)
47. Isolation and chemical and immunochemical characterization of the peanut-lectin-binding glycoprotein from human milk-fat-globule membranes. Fischer J, Klein PJ, Farrar GH, Hanisch FG, Uhlenbruck G, Biochem J 1984 224 581 589 6083779 (Pubitemid 15168451)
48. Overexpression of matrix Gla protein mRNA in malignant human breast cells: isolation by differential cDNA hybridization. Chen L, O'Bryan JP, Smith HS, Liu E, Oncogene 1990 5 1391 1395 2216462
49. Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Holmes MD, Pollak MN, Hankinson SE, Cancer Epidemiol Biomarkers Prev 2002 11 862 867 12223430 (Pubitemid 35014889)
50. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Key TJ, Appleby PN, Reeves GK, Roddam AW, Lancet Oncol 2010 11 530 542 20472501
51. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. De Souza Rocha Simonini P, Breiling A, Gupta N, Malekpour M, Youns M, Omranipour R, Malekpour F, Volinia S, Croce CM, Najmabadi H, Diederichs S, Sahin O, Mayer D, Lyko F, Hoheisel JD, Riazalhosseini Y, Cancer Res 2010 70 9175 9184 10.1158/0008-5472.CAN-10-1318 20978187